NCT01899820 - Evaluation of the Efficacy of Artemisinin Combination Therapy in Kenya | Biotech Hunter

Enrollment

2,100

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

July 31, 2015

Conditions

Malaria

Interventions

DRUG

Artemether lumefantrine

Artemether 20mg Lumefantrine 120mg

DRUG

Dihydroartemisinin piperaquine

Dihydroartemisinin 20mg Piperaquine 160mg

Trial Locations (7)

Busia district hospitals, Busia

Kisii district hospitals, Kisii

Kitale district hospitals, Kitale

Msambweni sub-district hospital, Msambweni

Machakos district hospital, Machakos

Malindi district hospitals, Malindi

Nyando district hospital, Nyando